NovoCure Ltd

Ownership Transactions Reported by 25 Insiders

Symbol
NVCR on Nasdaq
Location
No. 4 The Forum, Grenville Street, St. Helier, Jersey

Insiders trading volume in the past year

NovoCure Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cordova Ashley Chief Executive Officer $10.5M -$318K -2.93% Mar 4, 2025
William F. Doyle Executive Chairman, Director $8.09M Aug 2, 2022
Danziger Asaf Director $6.13M Jan 1, 2025
Weinberg Uri Chief Innovation Officer $5.51M -$179K -3.15% Mar 4, 2025
Groenhuysen Wilhelmus Cm Chief Operating Officer $5.26M Jun 28, 2024
Leonard Frank X EVP, Pres., Novocure Oncology $5.1M -$353K -6.47% Mar 4, 2025
Ben Arye Barak General Counsel $4.64M Mar 4, 2025
Puri Michal Nath Chief Human Resources Officer $4.46M -$40.6K -0.9% Mar 4, 2025
W. Anthony Vernon Director $4.04M -$23K -0.57% Jun 4, 2024
Pritesh Shah Chief Growth Officer $4.01M Nov 7, 2023
Paravasthu Mukund Chief Operating Officer $3.77M -$106K -2.72% Mar 4, 2025
Brackmann Christoph Chief Financial Officer $3.69M Mar 4, 2025
Leupin Nicolas Chief Medical Officer $3.39M -$19.8K -0.58% Mar 4, 2025
Giladi Moshe Chief Science Officer $2.41M Feb 27, 2024
Burke William Patrick Chief Human Resources Officer $2.39M Jun 30, 2023
Leung Gabriel Director $1.97M -$23K -1.16% Jun 4, 2024
Todd Longsworth General Counsel $1.26M Mar 8, 2022
Ely Benaim Chief Medical Officer $784K Jan 6, 2023
Martin Madden Director $572K Jun 5, 2024
Stafford Kristin Director $198K Jun 5, 2023
Timothy J. Scannell Director $172K -$23K -11.8% Jun 4, 2024
Sherilyn S. McCoy Director $115K Jun 9, 2021
Allyson J. Ocean Director $102K Jun 5, 2024
David Hung Director $102K Jun 5, 2024
Jeryl L. Hilleman Director $102K Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for NovoCure Ltd

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.